Literature DB >> 9367352

The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated.

M S Fabbrini1, D Carpani, I Bello-Rivero, M R Soria.   

Abstract

In contrast to two-chain urokinase (uPA), a chemical conjugate between uPA and native saporin (a cytotoxic plant seed ribosome-inactivating protein) did not require plasminogen activator inhibitors to be internalized. To dissect this pathway, we constructed a chimera consisting of the amino-terminal fragment (ATF) of human urokinase fused to a saporin isoform (SAP-3). The chimeric ATF-SAP toxin was expressed in Escherichia coli, purified, and characterized for its ribosome-inactivating activity. Besides being a potent inhibitor of protein synthesis in cell-free assays, ATF-SAP was specifically cytotoxic toward cells expressing human uPAR. Competition experiments indicated that both the human uPAR and the LDL-related receptor protein are involved in mediating the cell killing ability of ATF-SAP. We conclude that neither plasminogen activator inhibitors nor the catalytic moiety of urokinase are necessary to initiate these internalization pathways. Thus, saporin may play a role similar to plasminogen activator inhibitors in its ability to trigger internalization of uPAR-bound ligands through endocytic receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367352     DOI: 10.1096/fasebj.11.13.9367352

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

Review 1.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

2.  Preparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator.

Authors:  Ying Xiang; Qiying Li; Dehong Huang; Xianjun Tang; Li Wang; Yang Shi; Wenjun Zhang; Tao Yang; Chunyan Xiao; Jianghong Wang
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

3.  RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

Authors:  Sai MuraliKrishna Pulukuri; Christopher S Gondi; Sajani S Lakka; Aman Jutla; Norman Estes; Meena Gujrati; Jasti S Rao
Journal:  J Biol Chem       Date:  2005-08-26       Impact factor: 5.157

Review 4.  Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.

Authors:  Edward Rustamzadeh; Chunbin Li; Sekou Doumbia; Walter A Hall; Daniel A Vallera
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

Review 5.  Ribosome-inactivating proteins: from plant defense to tumor attack.

Authors:  Maddalena de Virgilio; Alessio Lombardi; Rocco Caliandro; Maria Serena Fabbrini
Journal:  Toxins (Basel)       Date:  2010-11-10       Impact factor: 4.546

6.  Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera.

Authors:  Alfredo Errico Provenzano; Riccardo Posteri; Francesco Giansanti; Francesco Angelucci; Sopsamorn U Flavell; David J Flavell; Maria Serena Fabbrini; Danilo Porro; Rodolfo Ippoliti; Aldo Ceriotti; Paola Branduardi; Riccardo Vago
Journal:  Microb Cell Fact       Date:  2016-11-14       Impact factor: 5.328

Review 7.  Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.

Authors:  Daniela Alfano; Paola Franco; Maria Patrizia Stoppelli
Journal:  Front Cell Dev Biol       Date:  2022-04-08

Review 8.  Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions).

Authors:  Maria Serena Fabbrini; Miku Katayama; Ikuhiko Nakase; Riccardo Vago
Journal:  Toxins (Basel)       Date:  2017-10-12       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.